Compound Detail
CHEMBL46516
FLUSPIRILENE 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL46516 |
| Name | FLUSPIRILENE |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | QOYHHIBFXOOADH-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
11
Targets
20
Activities
3
Assay Types
0
PK Parameters
20
Publications
7
Known Names
5
Indications
1
Mechanisms
Molecular Properties
475.6
MW (Da)
5.31
ALogP
3
HBA
1
HBD
35.6
PSA (Ų)
0.50
QED
1
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dopamine D2 receptor inhibitor | INHIBITOR | D(2) dopamine receptor | ✓ | ✓ |
Indications
Psychotic Disorders Anxiety Dementia Depressive Disorder Schizophrenia
ATC Classification
N05AG01
fluspirilene
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
IC50 14 meas. best 5.7
EC50 3 meas. best 5.92
Ki 3 meas. best 6.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.82 | 6.82 | 151.4 | 1 |
| Nociceptin receptor CHEMBL2014 | Ki | 6.3 | 6.3 | 500.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 5.92 | 5.92 | 1188.0 | 1 |
| Glycine receptor subunit alpha-1 CHEMBL5845 | EC50 | 5.92 | 5.92 | 1200.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.7 | 5.2857 | 1995.3 | 7 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.64 | 5.64 | 2300.0 | 1 |
| H4 CHEMBL1075452 | EC50 | 5.62 | 5.62 | 2400.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.5 | 5.385 | 3160.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 5.09 | 4.63 | 8086.0 | 3 |
| X-box-binding protein 1 CHEMBL1741176 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Protein RecA CHEMBL1741171 | EC50 | 4.7 | 4.7 | 20200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18024584 | 10.1073/pnas.0709695104 | H4 | 13 |
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 7 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| 25790278 | 10.1021/jm501873p | Glycine receptor subunit alpha-1 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 3 |
| - | 10.1101/2020.03.25.008482 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 24249037 | 10.1007/s11095-013-1232-z | No relevant target | 2 |
| - | 10.1101/2020.03.25.008482 | Vero C1008 | 2 |
| - | 10.1101/2020.03.25.008482 | ADMET | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 18027916 | 10.1021/jm070524a | No relevant target | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-dependent L-type calcium channel subunit alpha-1C | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 2859371 | 10.1021/jm50001a013 | Rattus norvegicus | 2 |
| - | 10.6019/CHEMBL4651402 | Vero C1008 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
Data from ChEMBL 36 via Core Engine